0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Hematopoietic vs Embryonic Sources for Stem Cell Research—Reply

Richard Burt, MD; John Kessler, MD; Yvonne Loh, MD
JAMA. 2008;299(23):2746-2747. doi:10.1001/jama.299.23.2746-c.
Text Size: A A A
Published online

Extract

In Reply: We agree with Dr Teitelbaum and colleagues that embryonic stem cells and induced pluripotent stem cells have extraordinary promise. However, in the review we and our coauthors were trying to point out that at the present time hematopoietic stem cells can be tested and used clinically, whereas the clinical use of embryonic stem cells still poses some technical challenges. We did not assert or intimate that the available evidence obviates the need to explore all sources of stem cells such as embryonic stem cells, neural stem cells, skin stem cells, or others. The review should simply be read as it was intended—a comprehensive overview of the clinical use of hematopoietic stem cells—and not as a commentary about the relative long-term value or merit of different types of stem cells.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

June 18, 2008
Steven Teitelbaum, MD; Shane Smith, PhD; William Neaves, PhD
JAMA. 2008;299(23):2746-2747. doi:10.1001/jama.299.23.2746-b.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();